Pharmacological characterization of bradykinin receptors coupled to phosphoinositide turnover in SV40-immortalized human trabecular meshwork cells

Experimental Eye Research

Volumn 63, Issue 6, 1996, Pages 631-637

  Sharif, N A ^a   Xu, S X ^a  

^a ALCON RESEARCH LTD   (United States)

Author keywords

Bradykinin; Hoe 140; Inositol phosphates; Outflow; Phosphoinositide turnover; T kinin; Trabecular meshwork cells

Indexed keywords

ANGIOTENSIN; BOMBESIN; BRADYKININ; BRADYKININ ANTAGONIST; BRADYKININ RECEPTOR; CHOLECYSTOKININ; ENDOTHELIN; ICATIBANT; PEPTIDE YY; PHOSPHATIDYLINOSITIDE; T KININ; UNCLASSIFIED DRUG;

AQUEOUS HUMOR OUTFLOW; ARTICLE; HUMAN; HUMAN CELL; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; TRABECULAR MESHWORK;

EID: 0030468721     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1006/exer.1996.0157     Document Type: Article

References (41)

1. Andley, U. P., Rhim, J. S., Chylack, L. T. and Fleming, T. P. (1994). Propagation and immortalization of human lens epithelial cells in culture. Invest. Ophthalmol. Vis. Sci. 35, 3094-102.
2. Arunlakshana, O. and Schild, H. O. (1959). Some quantitative uses of drug antagonists. Br. J. Pharmacol. Chemother. 14, 48-58.
3. 2 receptor. J. Pharmacol. Exp. Ther. 275, 1623-30.
4. Berridge, M. J., Downes, C. P. and Hanley, M. R. (1982). Lithium amplifies agonist-dependent phosphatidyl-inositol responses in brain and salivary gland. Biochem. J. 206, 587-95.
5. Bill, A. (1975). The drainage of aqueous humor. Invest. Ophthalmol. 14, 1-3.
6. Bynke, G., Hakanson, R., Horig, J. and Leander, S. (1983). Bradykinin contracts the pupillary sphincter and evokes ocular inflammation through release of neuronal substance P. Eur. J. Pharmacol. 91, 469-75.
7. Coca-Prados, M. and Wax, M. B. (1986). Transformation of human ciliary epithelial cells by simian virus 40: induction of cell proliferation and retention of adrenergic receptors. Proc. Natl. Acad. Sci. 83, 8754-8.
8. Cole, D. F. (1974). The site of breakdown of the blood-aqueous barrier under the influence of vasodilator drugs. Exp. Eye Res. 19, 591-607.
9. Cole, D. F. and Ungar, W. G. (1974). Action of bradykinin on intraocular pressure and pupillary diameter. Ophthalmol. Res. 6, 308-14.
10. Dray, A. and Perkins, M. (1993). Bradykinin and inflammatory pain. Trends Neurosci. 16, 99-104.
11. Elliott, P. J., Mackic, J. B., Graney, W. F., Bartus, R. T. and Zlokovic, B. V. (1995). RMP-7, bradykinin agonist, increases permeability of blood-ocular barriers in the guinea pig. Invest. Ophthalmol. Vis. Sci. 36, 2542-7.
12. Flugel, C., Tamm, E., Lutjen-Drecoll, E. and Stefani, F. H. (1992). Age-related loss of a smooth muscle actin in normal and glaucomatous human trabecular meshwork of different age-groups. J. Glaucoma 1, 165-73.
13. Friedman, Z., Bloom, E., Crook, R. B. and Polansky, J. R. (1990). Inositol phosphate production in cultured human trabecular meshwork (HTM) cells. Invest. Ophthalmol. Vis. Sci. 31S, 247.
14. Furchgott, R. F. (1972). The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In : Handbook of Experimental Pharmacology (Eds Eichler, O., Farah, A., Herken, H. and Welch, A. D.), Vol. 33, Pp. 283-335. Springer-Verlag: New York, U.S.A.
15. Gao, X., Stewart, J. M., Vavrek, R. J. and Greenbaum, L. M. (1993). Characterization of receptor-mediated actions of T-kinin. Biochem. Pharmacol. 46, 1607-12.
16. Grieson, I., Robins, E. and Howes, R. C. (1980). Preliminary observations on human trabecular meshwork cells in vitro. Graefes Arch. Clin. Exp. Ophthalmol. 212, 173-86.
17. Hall, J. M. (1992). Bradykinin receptors: pharmacological properties and biological roles. Pharmacol. Ther. 56, 131-90.
18. 2 receptor antagonist WIN-64338 in vivo and in vitro. Br. J. Pharmacol. 116, 3164-8.
19. 2 bradykinin receptors. Mol. Pharmacol. 45, 1-8.
20. Hock, F. J., Wirth, K., Ibus, U., Linz, W., Gerhards, H. J., Wiemer, G., St. Henke, G., Breipohl, G., Konig, W., Knolle, J. and Scholken, B. A. (1991). Hoe-140 a new potent and long acting bradykinin-antagonist : in vitro studies. Br. J. Pharmacol. 102, 769-73.
21. Lepple-Wienhues, A., Stahl, F. and Wiederholt, M. (1991). Differential smooth muscle-like contractile properties of trabecular meshwork and ciliary muscle. Exp. Eye Res. 53, 33-8.
22. Llobet, A., Gasul, X., Todo, P., Bergamini, M. V. W. and Gual, A. (1996). Effects of substance P, bradykinin, neuropeptide Y, Met-enkephalin and PGE2 on outflow facility (C) in bovine anterior segments in vitro. Invest. Ophthalmol. Vis. Sci. 37S, Abstr. No. 953.
23. 2 receptors on the venoconstrictor action of bradykinin. J. Pharmacol. Exp. Ther. 269, 1136-43.
24. Michel, A. D. and Whiting, R. L. (1984). Analysis of ligand binding data using a microcomputer. Brit. J. Pharmacol. 83, 460P.
25. Ocklind, A., Yousuzai, S. Y. K., Ghosh, S., Coca-Prados, M., Stjernchantz, J. and Abdel-Latif, A. A. (1996). Immortalization of cat iris sphincter smooth muscle cells by SV40 virus: growth, morphological, biochemical and pharmacological characteristics. Exp. Eye Res. 61, 535-45.
26. Pang, I.-H., Shade, D. L., Clark, A. F., Steely, H. T. and DeSantis, L. M. (1994). Preliminary characterization of a transformed cell strain derived from human trabecular meshwork. Curr. Eye Res. 13, 51-63.
27. Proud, D., Sweet, J., Stein, P., Settipane, R. A., Kagey-Sobotka, A., Freidlaender, M. H. and Lichtenstein, L. M. (1990). Inflammatory mediator release on conjunctival provocation of allergic subjects with allergen. J. Allergy Clin. Immunol. 85, 896-905.
28. 2-bradykinin receptor on a subclone of PC-12 cells. J. Neurochem. 56, 983-9.
29. 2 receptor characterization. Trends Pharmac. Sci. 11, 156-61.
30. Rohen, J. W. and Lutjen-Drecoll, E. (1989). Morphology of aqueous outflow pathways in normal and glaucomatous eyes. In The Glaucomas (Eds Ritch, R., Shields, M. B. and Krupin, T). Pp. 41-74. Mosby Company: St Louis, MO, U.S.A.
31. 2-bradykinin receptors in guinea pig brain regions, spinal cord and peripheral tissues. Neurochem. Int. 18, 89-96.
32. 2-antagonist-sensitive responses and receptor binding studies. Neurochem. Res. 12, 1313-20.
33. 1-selective antagonist for ocular use. Receptor binding and second messenger studies. J. Ocular Pharmacol. 10, 653-64.
34. Sharif, N. A., Xu, S. X., Miller, S. T., Gamache, D. A. and Yanni, J. M. (1996). Characterization of the ocular antiallergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases. J. Pharmac. Exp. Ther. 278, 1252-61.
35. 2-receptor. Neurosci. Lett. 86, 279-83.
36. Sharma, J. N. (1993). Therapeutic prospects of bradykinin receptor antagonists. Gen. Pharmacol. 24, 267-74.
37. 2 bradykinin receptors in bovine pulmonary artery endothelial cells. Mol. Pharmacol. 47, 525-34.
38. Tien, X.-Y., Wallace, L. J., Kachur, J. F., Won-Kim, S. and Gaginella, T. S. (1990). Characterization of Ile-Ser-bradykinin-induced changes in short circuit current across rat colon. J. Pharmac. Exp. Ther. 254, 1063-7.
39. Tripathi, R. C. and Tripathi, B. J. (1984). Effect of epinephrine in vitro on morphology, phagocytosis, and mitotic activity of human trabecular endothelium. Exp. Eye Res. 39, 731-44.
40. Wahlestedt, C., Bynke, G. and Hakanson, R. (1985). Pupillary constriction by bradykinin and capsaicin: mode of action. Eur. J. Pharmacol. 106, 577-83.
41. Wirth, K. J., Heitsch, H. and Scholkens, B. A. (1995). Kinin receptor antagonists: unique probes in basic and clinical research. Can. J. Physiol. Pharmacol. 73, 797-804.